Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 26 (8), 1206-8

[Clinical Observation of Target-Controlled Remifentanil Infusion Combined With Propofol and Doxapram in Painless Artificial Abortion]

[Article in Chinese]
Affiliations
  • PMID: 16939923
Randomized Controlled Trial

[Clinical Observation of Target-Controlled Remifentanil Infusion Combined With Propofol and Doxapram in Painless Artificial Abortion]

[Article in Chinese]
Zhi-min Tan et al. Nan Fang Yi Ke Da Xue Xue Bao.

Abstract

Objective: To observe the impacts of doxapram on anesthetic efficacy and respiratory and circulatory functions during anesthesia with remifentanil given by target-controlled infusion (TCI) combined with propofol in painless artificial abortion.

Methods: A total of 120 ASA I women requiring voluntarily painless artificial abortion were randomized into two equal groups. One group was given remifentanil by TCI at 2 ng/ml and propofol 1mg/kg (group I), and the other given remifentanil by TCI, propofol, and doxapram 0.6 mg/kg (group II). The anesthetic efficacy and respiratory and circulatory suppression during anesthesia were observed.

Results: Both of the two groups showed satisfactory anesthetic efficacy with comparable the BIS values (P>0.05). No significant difference was noted in the induction time and awaking time between the two groups (P>0.05), but group I had more serious respiratory and circulatory depression than group II (P<0.05).

Conclusion: Doxapram may attenuate respiratory and circulatory depression during anesthesia with remifentanil given by TCI combined with propofol in painless artificial abortion, and provide comparable anesthetic efficacy.

Similar articles

See all similar articles

Publication types

LinkOut - more resources

Feedback